Literature DB >> 9784544

Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes.

C M Bliss1, D T Golenbock, S Keates, J K Linevsky, C P Kelly.   

Abstract

Helicobacter pylori gastritis is characterized by leukocyte infiltration of the gastric mucosa. The aims of this study were to determine whether H. pylori-derived factors stimulate chemokine release from human monocytes and to ascertain whether H. pylori lipopolysaccharide (LPS) may be responsible for this effect. Human peripheral blood monocytes were exposed to an H. pylori water extract (HPE) or to purified H. pylori LPS. Levels of the chemokines interleukin-8 (IL-8), epithelial neutrophil-activating peptide 78 (ENA-78), and monocyte chemotactic protein 1 (MCP-1) were measured by enzyme-linked immunosorbent assay. The contribution of H. pylori LPS to monocyte activation was determined by using the LPS antagonist Rhodobacter sphaeroides lipid A (RSLA) and a blocking monoclonal antibody to CD14 (60bca). HPE increased monocyte secretion of IL-8, ENA-78, and MCP-1. Heat treatment of HPE did not reduce its ability to activate monocytes. Purified H. pylori LPS also stimulated monocyte chemokine production but was 1,000-fold less potent than Salmonella minnesota lipid A. RSLA blocked H. pylori LPS-induced monocyte IL-8 release in a dose-dependent fashion (maximal inhibition 82%, P < 0.001). RSLA also inhibited HPE-induced IL-8 release (by 93%, P < 0.001). The anti-CD14 monoclonal antibody 60bca substantially inhibited IL-8 release from HPE-stimulated monocytes (by 88%, P < 0.01), whereas the nonblocking anti-CD14 monoclonal antibody did not. These experiments with potent and specific LPS inhibitors indicate that the main monocyte-stimulating factor in HPE is LPS. H. pylori LPS, acting through CD14, stimulates human monocytes to release the neutrophil-activating chemokines IL-8 and ENA-78 and the monocyte-activating chemokine MCP-1. Despite its low relative potency, H. pylori LPS may play an important role in the pathogenesis of H. pylori gastritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784544      PMCID: PMC108670     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

Review 2.  How does Helicobacter pylori cause mucosal damage? The inflammatory response.

Authors:  P B Ernst; S E Crowe; V E Reyes
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

3.  Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria.

Authors:  S Birkholz; U Knipp; C Nietzki; R J Adamek; W Opferkuch
Journal:  FEMS Immunol Med Microbiol       Date:  1993-04

4.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Lipid A in Helicobacter pylori.

Authors:  I Mattsby-Baltzer; Z Mielniczuk; L Larsson; K Lindgren; S Goodwin
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils.

Authors:  P M Craig; M C Territo; W E Karnes; J H Walsh
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

7.  Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.

Authors:  D T Golenbock; R Y Hampton; N Qureshi; K Takayama; C R Raetz
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

8.  Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro.

Authors:  C P Kelly; J C O'Keane; J Orellana; P C Schroy; S Yang; J T LaMont; H R Brady
Journal:  Am J Physiol       Date:  1992-12

9.  Mechanisms involved in Helicobacter pylori-induced inflammation.

Authors:  N Yoshida; D N Granger; D J Evans; D G Evans; D Y Graham; D C Anderson; R E Wolf; P R Kvietys
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

10.  Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.

Authors:  U E Mai; G I Perez-Perez; J B Allen; S M Wahl; M J Blaser; P D Smith
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Overview: Helicobacter pylori and extragastric disease.

Authors:  Hidekazu Suzuki; Barry James Marshall; Toshifumi Hibi
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Immune response to H. pylori.

Authors:  Giovanni Suarez; Victor E Reyes; Ellen J Beswick
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 3.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells.

Authors:  Torsten Sterzenbach; Sae Kyung Lee; Birgit Brenneke; Franz von Goetz; David B Schauer; James G Fox; Sebastian Suerbaum; Christine Josenhans
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression.

Authors:  Susan G Elner; Howard R Petty; Victor M Elner; Ayako Yoshida; Zong-Mei Bian; Dongli Yang; Andrei L Kindezelskii
Journal:  Trans Am Ophthalmol Soc       Date:  2005

6.  Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagAHelicobacter pylori.

Authors:  Kristen Gaus; Yue Huang; Dawn A Israel; Susan L Pendland; Bolanle A Adeniyi; Gail B Mahady
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

7.  Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14.

Authors:  J Karhukorpi; Y Yan; S Niemela; J Valtonen; P Koistinen; T Joensuu; P Saikku; R Karttunen
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

8.  Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models.

Authors:  K A Eaton; D Kersulyte; M Mefford; S J Danon; S Krakowka; D E Berg
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 9.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli.

Authors:  Trisha J Rogers; Adrienne W Paton; Shaun R McColl; James C Paton
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.